Angiotensin-converting Enzyme Degrades Alzheimer Amyloid β-Peptide (Aβ); Retards Aβ Aggregation, Deposition, Fibril Formation; and Inhibits Cytotoxicity
We have demonstrated that the angiotensin-converting enzyme (ACE) genotype is associated with Alzheimer's disease (AD) in the Japanese population (1Hu J. Miyatake F. Aizu Y. Nakagawa H. Nakamura S. Tamaoka A. Takahashi R. Urakami K. Shoji M. Neurosci. Lett. 1999; 277: 65-67Crossref PubMed Scopu...
Guardado en:
Autores principales: | Jianguo Hu, Akira Igarashi, Makiko Kamata, Hachiro Nakagawa |
---|---|
Formato: | Artigo |
Lenguaje: | inglés |
Publicado: |
2001
|
Acceso en línea: | https://doi.org/10.1074/jbc.m104068200 http://www.jbc.org/article/S0021925819402937/pdf |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The N‐terminal active centre of human angiotensin‐converting enzyme degrades Alzheimer amyloid β‐peptide
por: Ryutaro Oba, et al.
Publicado: (2005) -
Angiotensin-Converting Enzyme Converts Amyloid β-Protein 1–42 (Aβ(1–42)) to Aβ(1–40), and Its Inhibition Enhances Brain Aβ Deposition
por: Zou, Kun, et al.
Publicado: (2007) -
Charge Dependent Retardation of Amyloid β Aggregation by Hydrophilic Proteins
por: Assarsson, Anna, et al.
Publicado: (2014) -
Charge Dependent Retardation of Amyloid β Aggregation by Hydrophilic Proteins
por: Anna Assarsson, et al.
Publicado: (2014) -
New Insights on How Metals Disrupt Amyloid β-Aggregation and Their Effects on Amyloid-β Cytotoxicity
por: Yuji Yoshiike, et al.
Publicado: (2001)